Haining Zhou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 3
- Surgery 13
- Esophageal Cancer Research and Treatment 5
- Co-authors
- Shoujun Tang (10 shared papers)Haiyang Hu (6 shared papers)A. van Oosterom (3 shared papers)Shengjie Tang (8 shared papers)Hang Yan (5 shared papers)Chao Qin (4 shared papers)Jianning Yao (8 shared papers)Xuexiu Zhang (7 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Medicine (2 papers)Cells (2 papers)BMC Cancer (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaJapanNetherlands
In The Last Decade
Haining Zhou
44 papers receiving 794 citations
Haining Zhou's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 158
- Oncology 178
- Pulmonary and Respiratory Medicine 150
- Molecular Biology 257
- Surgery 124
Countries citing papers authored by Haining Zhou
This map shows the geographic impact of Haining Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haining Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haining Zhou more than expected).
Fields of papers citing papers by Haining Zhou
This network shows the impact of papers produced by Haining Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haining Zhou. The network helps show where Haining Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Haining Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects Hit paper breakdown → | 2022 | 142 |
| 2 | 2019 | 75 | |
| 3 | 2012 | 70 | |
| 4 | 2022 | 58 | |
| 5 | 1992 | 49 | |
| 6 | 2018 | 48 | |
| 7 | 2021 | 46 | |
| 8 | 2021 | 35 | |
| 9 | 2019 | 30 | |
| 10 | 2018 | 27 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 20 | |
| 13 | 2022 | 18 | |
| 14 | 2018 | 18 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2024 | 10 | |
| 20 | 2017 | 10 |
About Haining Zhou
Haining Zhou is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 51 papers that have together received 808 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), Esophageal Cancer Research and Treatment (5 papers), MicroRNA in disease regulation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), Circular RNAs in diseases (3 papers) and Electrical and Bioimpedance Tomography (3 papers). The work is most often cited by research in Cancer Research (158 citations), Oncology (178 citations), Pulmonary and Respiratory Medicine (150 citations), Molecular Biology (257 citations) and Surgery (124 citations). Haining Zhou has collaborated with scholars based in China, Japan and Netherlands. Frequent co-authors include Shoujun Tang, Haiyang Hu, A. van Oosterom, Shengjie Tang, Hang Yan, Chao Qin, Jianning Yao, Xuexiu Zhang, Jun Zhang and Tao Liu. Their work appears in journals such as Journal of Clinical Oncology, Medicine, Cells, BMC Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.